Cargando…
Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
BACKGROUND: This “Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association Clinical Practice Statement 2022” is intended to provide clinicians an overview of Food and Drug Administration (FDA) approved anti-obesity medications and investigational anti-obesity agents in de...
Autores principales: | Bays, Harold E., Fitch, Angela, Christensen, Sandra, Burridge, Karli, Tondt, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662004/ https://www.ncbi.nlm.nih.gov/pubmed/37990711 http://dx.doi.org/10.1016/j.obpill.2022.100018 |
Ejemplares similares
-
Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Bays, Harold Edward, et al.
Publicado: (2022) -
Obesity history, physical exam, laboratory, body composition, and energy expenditure: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Burridge, Karlijn, et al.
Publicado: (2022) -
Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Tondt, Justin, et al.
Publicado: (2022) -
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Lazarus, Ethan, et al.
Publicado: (2022) -
Sleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Pennings, Nicholas, et al.
Publicado: (2022)